{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T07:00:53Z","timestamp":1792998053420,"version":"4.5.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["K01CA241073"],"award-info":[{"award-number":["K01CA241073"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Cervical cancer screening rates are declining in the US, with persistent disparities among vulnerable populations. Strategies to better reach under-screened communities are needed. The COVID pandemic sparked major shifts in healthcare delivery, including the accelerated development and adoption of rapid diagnostic testing, broadened access to remote care, and growing consumer demand for self-testing, which could be leveraged for cervical cancer. Rapid tests for the detection of Human Papillomavirus (HPV) have the potential to improve cervical cancer screening coverage, and if coupled with patient-collected cervicovaginal samples, create an opportunity for self-testing. The objectives of this study were: 1) to examine whether COVID influenced clinician perspectives of rapid testing as a screening modality; and 2) to assess clinician awareness, perceived benefits and limitations, and willingness to adopt point-of-care HPV testing, patient self-sampling, and rapid HPV self-testing with self-collected samples. The methodology adopted consisted of an online cross-sectional survey (n = 224) and in-depth interviews (n = 20) were conducted with clinicians who perform cervical cancer screening in Indiana, ranked in the top ten states for cervical cancer mortality and with marked disparities across socio-demographic groups. The main findings show that about half the clinicians reported that the COVID pandemic had influenced their views on rapid testing as a screening modality both positively (greater public acceptability of rapid testing and impact on patient care) and negatively (concerns regarding accuracy of rapid tests). The majority of clinicians (82%) were willing to adopt rapid HPV testing at the point-of-care, while only 48% were willing to adopt rapid HPV self-testing with self-collected samples. In-depth interviews revealed provider concerns around patients\u2019 ability to collect their own sample, report results correctly, and return to the clinic for follow-up and other preventive care. Addressing clinician concerns about self-sampling and rapid HPV testing, such as ensuring that rapid tests include sample adequacy controls, is necessary to mitigate barriers to adoption for cervical cancer screening.<\/jats:p>","DOI":"10.1371\/journal.pone.0282853","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T18:46:57Z","timestamp":1678387617000},"page":"e0282853","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-4397","authenticated-orcid":true,"given":"Natalia M.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5616-7913","authenticated-orcid":true,"given":"Luke P.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Claure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara N.","family":"Balian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-0713","authenticated-orcid":true,"given":"Victoria L.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele R.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"issue":"1","key":"pone.0282853.ref001","doi-asserted-by":"crossref","first-page":"e2143582","DOI":"10.1001\/jamanetworkopen.2021.43582","article-title":"Assessment of US Preventive Services Task Force Guideline\u2013Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.","volume":"5","author":"R Suk","year":"2022","journal-title":"JAMA Netw Open."},{"key":"pone.0282853.ref002","unstructured":"Increase the proportion of females who get screened for cervical cancer\u2014C\u201109\u2014Healthy People 2030 | health.gov [Internet]. [cited 2022 May 17]. Available from: https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/cancer\/increase-proportion-females-who-get-screened-cervical-cancer-c-09."},{"key":"pone.0282853.ref003","article-title":"The disparity of cervical cancer in diverse populations","author":"LS Downs","year":"2008","journal-title":"Gynecol Oncol"},{"key":"pone.0282853.ref004","doi-asserted-by":"crossref","first-page":"106400","DOI":"10.1016\/j.ypmed.2020.106400","article-title":"Cervical cancer screening in the United States: Challenges and potential solutions for underscreened groups.","volume":"144","author":"LN Fuzzell","year":"2021","journal-title":"Prev Med"},{"key":"pone.0282853.ref005","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.","author":"ETH Fontham","year":"2020","journal-title":"CA Cancer J Clin."},{"key":"pone.0282853.ref006","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [Internet]. [cited 2022 May 4]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240030824."},{"key":"pone.0282853.ref007","article-title":"Improving Resilience and Equity in Cancer Screening: Innovations to Increase Screening","author":"President\u2019s Cancer Panel","year":"2021","journal-title":"Nactional Cancer Institute"},{"key":"pone.0282853.ref008","author":"Christopher Mast","year":"2020","journal-title":"Alejandro Delayed Cancer Screeings\u2014A Second Look"},{"issue":"6","key":"pone.0282853.ref009","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/jnci\/djaa089","article-title":"How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention","volume":"113","author":"S Feldman","year":"2021","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"2","key":"pone.0282853.ref010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s43018-021-00178-9","article-title":"Eliminating cervical cancer in the COVID-19 era.","volume":"2","author":"O Ginsburg","year":"2021","journal-title":"Nat Cancer."},{"issue":"5","key":"pone.0282853.ref011","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1016\/S2214-109X(20)30522-2","article-title":"Participatory innovation for human papillomavirus screening to accelerate the elimination of cervical cancer","volume":"9","author":"NM Rodriguez","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"7","key":"pone.0282853.ref012","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ijc.34151","article-title":"Redesign of a rapid, low\u2010cost HPV typing assay to support risk\u2010based cervical screening and management","volume":"151","author":"KT Desai","year":"2022","journal-title":"Int J Cancer"},{"issue":"9","key":"pone.0282853.ref013","doi-asserted-by":"crossref","first-page":"e1336","DOI":"10.1016\/S2214-109X(22)00271-6","article-title":"Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).","volume":"10","author":"AJB Vallely","year":"2022","journal-title":"Lancet Glob Health."},{"issue":"S4","key":"pone.0282853.ref014","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1136\/sextrans-2016-053071","article-title":"Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis.","volume":"93","author":"I Toskin","year":"2017","journal-title":"Sex Transm Infect."},{"key":"pone.0282853.ref015","article-title":"Use of At-Home COVID-19 Tests\u2014United States, August 23, 2021\u2013March 12, 2022","author":"B. Rader","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"pone.0282853.ref016","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/ijc.33482","article-title":"Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+: A randomized study","volume":"148","author":"R Aarnio","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"pone.0282853.ref017","doi-asserted-by":"crossref","first-page":"e001351","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis","volume":"4","author":"PT Yeh","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"8","key":"pone.0282853.ref018","first-page":"597","article-title":"Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.","volume":"63","author":"TR Madzima","year":"2017","journal-title":"Can Fam Physician"},{"issue":"7","key":"pone.0282853.ref019","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11606-018-4404-z","article-title":"HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial.","volume":"33","author":"O Carrasquillo","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"3","key":"pone.0282853.ref020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0969141319885994","article-title":"Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits","volume":"27","author":"C Malone","year":"2020","journal-title":"J Med Screen"},{"issue":"9","key":"pone.0282853.ref021","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1089\/jwh.2015.5469","article-title":"Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening.","volume":"25","author":"K Ilangovan","year":"2016","journal-title":"J Womens Health"},{"issue":"1","key":"pone.0282853.ref022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","article-title":"The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis.","volume":"93","author":"EJ Nelson","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"1","key":"pone.0282853.ref023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/biores.2018.0040","article-title":"Acceptability of Human Papillomavirus Self-Sampling Among a National Sample of Women in the United States.","volume":"8","author":"E Bishop","year":"2019","journal-title":"BioResearch Open Access.30"},{"key":"pone.0282853.ref024","year":"2020","journal-title":"National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13\u201317 Years\u2014United States"},{"issue":"4","key":"pone.0282853.ref025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1634\/theoncologist.2013-0340","article-title":"Current Cervical Cancer Screening Knowledge, Awareness, and Practices Among U.S. Affiliated Pacific Island Providers: Opportunities and Challenges.","volume":"19","author":"JS Townsend","year":"2014","journal-title":"The Oncologist."},{"issue":"1","key":"pone.0282853.ref026","doi-asserted-by":"crossref","first-page":"e0145215","DOI":"10.1371\/journal.pone.0145215","article-title":"Awareness, Interest, and Preferences of Primary Care Providers in Using Point-of-Care Cancer Screening Technology.","volume":"11","author":"CS Kim","year":"2016","journal-title":"PLOS ONE"},{"issue":"8","key":"pone.0282853.ref027","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/IGC.0b013e3181a83dd0","article-title":"Preventing Cervical Cancer: Stakeholder Attitudes Toward CareHPV-Focused Screening Programs in Roi-et Province, Thailand.","volume":"19","author":"LA Trope","year":"2009","journal-title":"Int J Gynecol Cancer."},{"issue":"5","key":"pone.0282853.ref028","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ypmed.2013.04.012","article-title":"Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers","volume":"57","author":"KB Roland","year":"2013","journal-title":"Prev Med"},{"issue":"10","key":"pone.0282853.ref029","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/03630242.2016.1243608","article-title":"Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.","volume":"57","author":"ML Katz","year":"2017","journal-title":"Women Health.26"},{"issue":"6","key":"pone.0282853.ref030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/jwh.2016.5965","article-title":"Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.","volume":"26","author":"C Mao","year":"2017","journal-title":"J Womens Health"},{"key":"pone.0282853.ref031","volume-title":"The Coding Manual for Qualitative Researchers","year":"2022"},{"issue":"2","key":"pone.0282853.ref032","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/diagnostics12020533","article-title":"Understanding Healthcare Professionals\u2019 Perspectives on Point-of-Care Testing.","volume":"12","author":"S Teebagy","year":"2022","journal-title":"Diagnostics."},{"key":"pone.0282853.ref033","unstructured":"National Cancer Institute. Available from: https:\/\/prevention.cancer.gov\/major-programs\/nci-cervical-cancer-last-mile-initiative."},{"issue":"22","key":"pone.0282853.ref034","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1056\/NEJMp2025631","article-title":"Rethinking Covid-19 Test Sensitivity\u2014A Strategy for Containment","volume":"383","author":"MJ Mina","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0282853.ref035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12905-021-01493-0","article-title":"Significance of the viral load of high-risk HPV in the diagnosis and prediction of cervical lesions: a retrospective study.","volume":"21","author":"Y Liu","year":"2021","journal-title":"BMC Womens Health."},{"issue":"2","key":"pone.0282853.ref036","doi-asserted-by":"crossref","first-page":"200.e1","DOI":"10.1016\/j.ajog.2020.08.026","article-title":"Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program","volume":"224","author":"DL Loopik","year":"2021","journal-title":"Am J Obstet Gynecol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0282853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T18:47:24Z","timestamp":1678387644000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0282853"}},"subtitle":[],"editor":[{"given":"Ramona","family":"Bongelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0282853","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]}}}